Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ OCIAD2 Antibody Blocking Peptide
SDP

Catalog No. NBP177085E
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP177085E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP177085E Supplier Novus Biologicals™ Supplier No. NBP177085PEP

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

17 amino acids near the amino terminus of OCIAD2. Source: Synthetic (Accession #: NP_001014446) The OCIAD2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 132299
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-77085. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias MGC45416, OCIA domain containing 2, OCIA domain-containing protein 2, ovarian carcinoma immunoreactive antigen, ovarian carcinoma immunoreactive antigen-like protein
Gene Symbol OCIAD2
Product Type OCIAD2
Quantity 0.05 mg
Regulatory Status RUO
Source Synthetic
Termination 17 amino acids near the amino terminus of OCIAD2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.